Millions of U.S. parents are crossing their fingers again this week that Covid-19 vaccines will soon be available for younger age groups. An advisory panel to the Food and Drug Administration voted unanimously on Wednesday to recommend that the agency authorize the Pfizer-BioNTech and Moderna vaccines for use in very young children.
On Friday and Saturday, a Centers for Disease Control and Prevention advisory committee will meet to finalize their recommendations. After multiple delays in the review process of Pfizer’s vaccine, pediatricians are hopeful that both vaccines will become available early next week. The Pfizer vaccine would cover children aged 6 months through 4 years old, and the Moderna vaccine would cover children aged 6 months through 5 years old. Five million doses of each vaccine were made available for pharmacies and other medical establishments to order starting two weeks ago, so if the vaccines are authorized, they will be ready to go into arms immediately.